Similar Search Results

Keeping the Doctor Away : Experimental Evidence on Investment in Preventative Health Products

Meredith, Jennifer - 2013

curves for health products in Kenya, Guatemala, India, and Uganda and test whether (1) information about health risk, (2 …

Persistent link: https://www.econbiz.de/10013077947

Black Box Warnings and Drug Safety : Examining the Determinants and Timing of Fda Warning Labels

Begosh, Allan - 2013

Comparing the safety of prescription drugs over time is difficult due to the paucity of reliable quantitative measures of drug safety. Both the academic literature and popular press have focused on drug withdrawals as a proxy for breakdowns in the drug safety system. This metric, however, is...

Persistent link: https://www.econbiz.de/10012754051

The Effect of Deceptive Advertising on Consumption of the Advertised Good and its Substitutes : the Case of Over-the-Counter Weight Loss Products

Cawley, John H. - 2013

This paper is the first to estimate the impact of exposure to deceptive advertising on consumption of the advertised product and its substitutes. We study the market for over-the-counter (OTC) weight-loss products, a market in which deceptive advertising is rampant and products are generally...

Persistent link: https://www.econbiz.de/10013085499

When is Prevention More Profitable than Cure? The Impact of Time-Varying Consumer Heterogeneity

Kremer, Michael - 2013

We argue that in pharmaceutical markets, variation in the arrival time of consumer heterogeneity creates differences between a producer's ability to extract consumer surplus with preventives and treatments, potentially distorting R&D decisions. If consumers vary only in disease risk, revenue...

Persistent link: https://www.econbiz.de/10013085502

Patient Responses to Incentives in Consumer-Directed Health Plans : Evidence from Pharmaceuticals

Huckfeldt, Peter J. - 2015

use of pharmaceuticals for chronic diseases. We compare two large firms where nearly all employees were switched to CDHPs … to firms with conventional health insurance plans. In the first firm's CDHP, pharmaceuticals were subject to the … deductible, while in the second firm pharmaceuticals were exempt. Employees in the first firm shifted the timing of drug …

Persistent link: https://www.econbiz.de/10013028554

Prescription Drugs, Medical Care, and Health Outcomes : A Model of Elderly Health Dynamics

Yang, Zhou; Gilleskie, Donna; Norton, Edward C. - 2021

There is much debate about whether the Medicare Prescription Drug Bill -- the greatest expansion of Medicare benefits since its creation in 1965 -- will improve the health of elderly Americans, and how much it will cost. We model how insurance affects medical care utilization, and subsequently,...

Persistent link: https://www.econbiz.de/10013223173

The Diversity of Concentrated Prescribing Behavior : an Application to Antipsychotics

Levine Taub, Anna - 2012

Physicians prescribing drugs for patients with schizophrenia and related conditions are remarkably concentrated in their choice among antipsychotic drugs. In 2007 the single antipsychotic drug prescribed by a physician accounted for 66% of all antipsychotic prescriptions written by that...

Persistent link: https://www.econbiz.de/10013115174

Policy Response to Pandemic Influenza : The Value of Collective Action

Bobashev, Georgiy V. - 2011

This paper examines positive externalities and complementarities in the use of antiviral pharmaceuticals to mitigate …

Persistent link: https://www.econbiz.de/10013122651

Plan Selection in Medicare Part D : Evidence from Administrative Data

Heiss, Florian - 2012

We study the Medicare Part D prescription drug insurance program as a bellwether for designs of private, non-mandatory health insurance markets, focusing on the ability of consumers to evaluate and optimize their choices of plans. Our analysis of administrative data on medical claims in Medicare...

Persistent link: https://www.econbiz.de/10013104980

Health Care Adherence and Personalized Medicine

Egan, Mark - 2014

Non-adherence in health care results when a patient does not initiate or continue care that a provider has recommended. Previous research identifies non-adherence as a major source of waste in US health care, totaling approximately 2.3% of GDP, and have proposed a plethora of interventions to...

Persistent link: https://www.econbiz.de/10013050160